Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancer

Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancer

Pancreatic cancer remains one of the greatest challenges in oncology for which therapeutic intervention is urgently needed. We previously demonstrated that the intra-tumoral gene transfer of somatostatin receptor 2, to combat tumor aggressiveness, or of deoxycytidine kinase and uridylate monophospha...

Full description

Bibliographic Details
Main Authors: Odile Barbey, Hubert Lulka, Naima Hanoun, Hafid Belhadj-Tahar, Fabienne Vernejoul, Gilles Cambois, Michèle Tiraby, Louis Buscail, Fabian Gross, Pierre Cordelier
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
pancreatic cancer
non-viral gene therapy
resistance to treatment
chemotherapy
preclinical regulatory experiments
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050123000414

Internet

http://www.sciencedirect.com/science/article/pii/S2329050123000414

Similar Items